Kynapid vernakalant IV regulatory update

An FDA advisory committee voted 6-2 to recommend approval of Kynapid vernakalant IV to treat acute atrial fibrillation (AF). FDA told the Cardiovascular and Renal Drugs Advisory Committee that Kynapid...